Safety,Usability and Compliance of Using C-Scan System for Providing Information on Colonic Polypoid Lesions and Masses

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

January 1, 2020

Study Completion Date

February 15, 2020

Conditions
Colo-rectal Cancer
Interventions
DEVICE

C-Scan procedure

"The subjects will be connected to the C-Scan Track and after successful system's activation. The subject will be asked to ingest the C-Scan Capsule with some water, contrast media The subject will be required to ingest daily dose (3 X 15 ml) of contrast media. Capsule procedure is completed upon capsule excretion.~o Collecting procedure related data: Technical performance in normal daily routine, Segmental transit time,Procedure duration, Number of Bowel movements , Similarity between C-Scan results and colonoscopy Etc,"

Trial Locations (1)

55905

Mayoclinic, Rochester

All Listed Sponsors
lead

Check-Cap Ltd.

INDUSTRY

NCT03735407 - Safety,Usability and Compliance of Using C-Scan System for Providing Information on Colonic Polypoid Lesions and Masses | Biotech Hunter | Biotech Hunter